Dapagliflozin 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX41B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,492
Award facts
- Contract value 100% obligated
- $5,492.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $5,492.03 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dapagliflozin is a diabetes management medication commonly used in military and veteran healthcare systems supported by DLA Medical Supply Chain operations.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders across multiple therapeutic domains, demonstrating its capability to meet DLA's complex and varied medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FX41B?
SPE2DB25FX41B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FX41B worth?
The government has obligated $5,492 on SPE2DB25FX41B.
Is contract SPE2DB25FX41B an order under another contract?
Yes. SPE2DB25FX41B is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX41B competed?
The extent of competition for SPE2DB25FX41B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award